Cargando…

Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer

Related studies have reported that cystatin C (Cys C), uric acid (UA) and lactate dehydrogenase (LDH) affect tumor growth and invasion; however, the correlation between them and the prognosis of patients with small-cell lung cancer (SCLC) remains unclear. The present study aimed to investigate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haocheng, Shan, Dongfeng, Dong, Ya, Yang, Xue, Zhang, Linwei, Yu, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716718/
https://www.ncbi.nlm.nih.gov/pubmed/33365084
http://dx.doi.org/10.3892/ol.2020.12334
_version_ 1783619218811387904
author Wang, Haocheng
Shan, Dongfeng
Dong, Ya
Yang, Xue
Zhang, Linwei
Yu, Zhuang
author_facet Wang, Haocheng
Shan, Dongfeng
Dong, Ya
Yang, Xue
Zhang, Linwei
Yu, Zhuang
author_sort Wang, Haocheng
collection PubMed
description Related studies have reported that cystatin C (Cys C), uric acid (UA) and lactate dehydrogenase (LDH) affect tumor growth and invasion; however, the correlation between them and the prognosis of patients with small-cell lung cancer (SCLC) remains unclear. The present study aimed to investigate the effects of serum Cys C, UA and LDH concentrations on the prognosis of patients with SCLC prior to initial treatment, in order to identify potential targets for determining the clinical outcome of patients with SCLC. A total of 205 patients with SCLC were enrolled in the present study, and the clinical and laboratory data were obtained from the medical records. The receiver operating characteristic curve was used to determine the optimal cut-off values of Cys C, UA and LDH, while the Kaplan-Meier method was used for survival analysis. The Cox proportional hazard model was used for univariate and multivariate analyses to identify independent prognostic factors. The optimal cut-off values for Cys C, UA and LDH were 0.775 mg/l, 296.45 µmol/l and 198.5 U/l, respectively. The survival curves demonstrated that progression-free survival (PFS) and overall survival (OS) time were shorter in patients with high levels of Cys C, UA and LDH prior to chemotherapy. Univariate and multivariate analyses indicated that LDH concentration prior to chemotherapy may be an independent prognostic factor for both PFS and OS in patients with SCLC, while Cys C concentration may be an independent prognostic factor for PFS in patients with SCLC. The concentrations of Cys C, UA and LDH prior to chemotherapy were associated with prognosis of patients with SCLC. PFS and OS time were shorter, and the prognosis was poor in patients with elevated serum levels of Cys C, UA and LDH. Taken together, the results of the present study suggest that high concentrations of LDH and Cys C prior to chemotherapy may indicate rapid disease progression, thus it is important to focus on the progression and recurrence of the disease. High LDH concentration may also indicate a shorter survival time.
format Online
Article
Text
id pubmed-7716718
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77167182020-12-22 Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer Wang, Haocheng Shan, Dongfeng Dong, Ya Yang, Xue Zhang, Linwei Yu, Zhuang Oncol Lett Articles Related studies have reported that cystatin C (Cys C), uric acid (UA) and lactate dehydrogenase (LDH) affect tumor growth and invasion; however, the correlation between them and the prognosis of patients with small-cell lung cancer (SCLC) remains unclear. The present study aimed to investigate the effects of serum Cys C, UA and LDH concentrations on the prognosis of patients with SCLC prior to initial treatment, in order to identify potential targets for determining the clinical outcome of patients with SCLC. A total of 205 patients with SCLC were enrolled in the present study, and the clinical and laboratory data were obtained from the medical records. The receiver operating characteristic curve was used to determine the optimal cut-off values of Cys C, UA and LDH, while the Kaplan-Meier method was used for survival analysis. The Cox proportional hazard model was used for univariate and multivariate analyses to identify independent prognostic factors. The optimal cut-off values for Cys C, UA and LDH were 0.775 mg/l, 296.45 µmol/l and 198.5 U/l, respectively. The survival curves demonstrated that progression-free survival (PFS) and overall survival (OS) time were shorter in patients with high levels of Cys C, UA and LDH prior to chemotherapy. Univariate and multivariate analyses indicated that LDH concentration prior to chemotherapy may be an independent prognostic factor for both PFS and OS in patients with SCLC, while Cys C concentration may be an independent prognostic factor for PFS in patients with SCLC. The concentrations of Cys C, UA and LDH prior to chemotherapy were associated with prognosis of patients with SCLC. PFS and OS time were shorter, and the prognosis was poor in patients with elevated serum levels of Cys C, UA and LDH. Taken together, the results of the present study suggest that high concentrations of LDH and Cys C prior to chemotherapy may indicate rapid disease progression, thus it is important to focus on the progression and recurrence of the disease. High LDH concentration may also indicate a shorter survival time. D.A. Spandidos 2021-01 2020-11-25 /pmc/articles/PMC7716718/ /pubmed/33365084 http://dx.doi.org/10.3892/ol.2020.12334 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wang, Haocheng
Shan, Dongfeng
Dong, Ya
Yang, Xue
Zhang, Linwei
Yu, Zhuang
Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title_full Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title_fullStr Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title_full_unstemmed Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title_short Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
title_sort correlation analysis of serum cystatin c, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716718/
https://www.ncbi.nlm.nih.gov/pubmed/33365084
http://dx.doi.org/10.3892/ol.2020.12334
work_keys_str_mv AT wanghaocheng correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer
AT shandongfeng correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer
AT dongya correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer
AT yangxue correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer
AT zhanglinwei correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer
AT yuzhuang correlationanalysisofserumcystatincuricacidandlactatedehydrogenaselevelsbeforechemotherapyontheprognosisofsmallcelllungcancer